First-in-human ex-vivo validation of carbonic anhydrase IX-PET for high-risk renal cancer (CAT-VHL - PNRR-POC-2023-12377493). - Larcher A; Gelardi F; Antunovic L; Savi A; Olivieri M; Rainone P; Sollini M; Moresco RM; Re C; Cei F; Belladelli F; Musso G; et al. (Theranostics, 2026)